Treatment
Treatment clinical trials
We’re tracking 8,599 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT06522555RecruitingPhase 3
Testing Pola-ZR2 vs ZR2 for older adults with lymphoma
This trial tests a new combination of drugs (Pola-ZR2) against a standard combination (ZR2) for older adults with newly diagnosed diffuse large B-cell lymphoma. It aims to see if the new mix is more effective and safe.
ShanghaiAges 70 years+ - NCT06522750Recruiting
Periodic fasting for long COVID in adults
This study tests whether periodic fasting can help adults with long COVID. You may qualify if you are 18-64, have had COVID symptoms for at least 12 weeks, have a normal weight and low iron stores.
EttelbruckAges 18–64 - NCT06522919RecruitingPhase 2
Immunotherapy and chemotherapy for advanced colorectal cancer
This trial tests a sequence of treatments for people with a specific type of advanced colorectal cancer (called pMMR or MSS) that has not responded to earlier therapies. Patients first receive an immunotherapy combination (pembrolizumab plus a personalized dendritic cell vaccine) followed by a chemotherapy pill (trifluridine/tipiracil) plus bevacizumab. The goal is to see if this sequence can help control the cancer.
Meldola, Forlì CesenaAges 18 years+ - NCT06523127Recruiting
Life support decisions and quality of life after severe brain injury
This study looks at patients with severe brain injuries who were in the ICU in 2022. It explores how decisions about life-sustaining treatment affect their quality of life two years later.
Saint-EtienneAges 18 years+ - NCT06524570RecruitingPhase 1
Focused ultrasound plus immune therapy for advanced cancer
This trial tests a new treatment that combines a special type of focused ultrasound (called histotripsy) with an immune checkpoint inhibitor to boost the immune system's attack on cancer. It is for people with advanced cancer that has not responded to standard treatments.
Utrecht, UtrechtAges 18 years+ - NCT06524882RecruitingPhase 3
Special glasses for lazy eye in children 8 to 12 years old
This trial tests if special movies or games viewed through a headset can improve vision in children with lazy eye (amblyopia). It compares these treatments to wearing glasses alone.
Birmingham, AlabamaAges 8–12 - NCT06525220RecruitingPhase 3
New drug combo vs. standard for head and neck cancer
This trial tests a new combination of two immunotherapy drugs (petosemtamab plus pembrolizumab) compared to pembrolizumab alone for people with head and neck cancer that has spread or come back and cannot be cured locally. It may be an option if your cancer has a certain protein (PD-L1) and you haven't had prior cancer treatment for this stage.
Mobile, AlabamaAges 18 years+ - NCT06525285Recruiting
Gum graft techniques for treating severe gum recession
This trial compares two different gum grafting methods to treat advanced gum recession in front teeth. It aims to see if adding a special connective tissue wall helps improve root coverage and gum health.
Bengaluru, KarnatakaAges 18–60 - NCT06526247Recruiting
Testing programs for intimate partner violence in Washington state
This study tests support programs for men who have been court-referred for intimate partner violence in Washington state. It also includes their partners to see how well the programs work.
Boston, MassachusettsAges 18 years+ - NCT06526208RecruitingPhase 2
Marijuana-based compound for anxiety in autistic adults
This study tests a marijuana-based compound (similar to CBD but not psychoactive) to see if it helps reduce anxiety in autistic adults. You would take a daily capsule and be monitored for 12 weeks.
Phoenix, ArizonaAges 18–45 - NCT06526299RecruitingPhase 2
Higher dose of targeted radiation for prostate cancer with low PSMA levels
This trial tests a higher dose of a radioactive drug (177Lu-PSMA-617) for men whose prostate cancer has spread and does not produce much of a protein called PSMA on scans. The goal is to see if a stronger dose can work better than the standard dose.
San Francisco, CaliforniaAges 18 years+ - NCT06526923RecruitingPhase 1/Phase 2
Testing SP-101 gene therapy for cystic fibrosis
This trial tests a new gene therapy called SP-101 for cystic fibrosis. It aims to see if SP-101 is safe and effective for improving lung function.
Kansas City, KansasAges 18–65 - NCT06527664Recruiting
Custom hip implant for failed arthritis treatments
This trial tests a custom-made hip socket implant for people who have had a failed hip replacement or arthritis treatment. It aims to see if a personalized implant can provide a better solution.
BolognaAges 18 years+ - NCT06527963Recruiting
Balloon types for fistula narrowing in dialysis patients
This trial compares two types of balloons used to open up narrowed areas in the blood vessels of dialysis patients. It aims to find which balloon works better for keeping the fistula working well.
Zhengzhou, HenanAges 18–75 - NCT06527820Recruiting
Talking about buprenorphine and methadone for opioid use
This trial is testing a conversation approach to help people start medication for opioid use disorder (like buprenorphine or methadone). It may be a good fit if you've had an overdose, opioid withdrawal, or other serious problem from opioid use and are not already on these medications.
Springfield, MassachusettsAges 18 years+ - NCT06528574Recruiting
Pain after root canal cleaning methods
This trial compares two methods of cleaning a tooth's root canal to see which causes less pain after the procedure. It is for people with a specific type of tooth nerve pain (acute pulpitis) in a lower back molar.
Cleveland, OhioAges 18–50 - NCT06528613Recruiting
BPH symptom study with combo treatment
This study is for men with moderate to severe BPH symptoms who haven't responded well to one medicine alone. It tests a combination of two drugs (solifenacin and tamsulosin) to see if they improve symptom control and quality of life.
Athens, GreeceAges 18–100 - NCT06529081Recruiting
Radiation schedule for advanced small-cell lung cancer after chemo-immunotherapy
This study tests a specific radiation schedule (15 sessions to the chest and up to 3 sessions to other spots) for people with advanced small-cell lung cancer that responded to first-line chemo combined with immunotherapy. The goal is to see if this radiation approach can improve control of the disease.
LublinAges 18 years+ - NCT06529185Recruiting
Breathing device for COPD patients with leg pain
This trial tests if a breathing device (Breather) can help men with COPD who also have leg pain from blocked leg arteries (intermittent claudication) walk farther without pain. If you have both conditions, this study may offer a new way to improve your walking ability.
DokkiAges 50–60 - NCT06530004Recruiting
Rituximab for childhood nephrotic syndrome: a follow-up study
This study follows children with nephrotic syndrome (a kidney condition causing swelling) who are being treated for the first time with rituximab. It aims to see how well the medication works long-term.
Xiamen, FujianAges 1–18 - NCT06530550RecruitingPhase 2
PI3K inhibitor for relapsed T/NK-cell lymphoma
This trial tests a targeted therapy called a PI3K inhibitor for people whose T-cell or NK-cell lymphoma has returned or not improved after other treatments. It aims to see if the drug can shrink or control the lymphoma.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06530732RecruitingPhase 3
Neck drainage surgery for Alzheimer's disease
This study tests a new surgical treatment for Alzheimer's disease. The surgery aims to improve drainage in the neck to help clear waste from the brain. This is a first-of-its-kind pilot study to see if it is safe and might help thinking and memory.
Hangzhou, ZhejiangAges Any age - NCT06531980Recruiting
Digital app for teens with mild to moderate anxiety
This trial tests a digital app to help teens with mild to moderate anxiety. If you are 13–16, live in Bergen, and feel anxious often, this app might help you manage your worries and get back to doing things you enjoy.
Bergen, VestlandAges 13–16 - NCT06532006RecruitingPhase 3
HLX22 plus trastuzumab and chemo for HER2+ stomach cancer
This trial tests adding a new drug, HLX22, to the standard combination of trastuzumab and chemotherapy for people with HER2-positive stomach or gastroesophageal junction cancer that hasn't been treated yet. The goal is to see if this three-drug mix works better than the usual two-drug approach.
Anaheim, CaliforniaAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,599 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.